Cell Reports (Apr 2019)

Loss of p53 Causes Stochastic Aberrant X-Chromosome Inactivation and Female-Specific Neural Tube Defects

  • Alex R.D. Delbridge,
  • Andrew J. Kueh,
  • Francine Ke,
  • Natasha M. Zamudio,
  • Farrah El-Saafin,
  • Natasha Jansz,
  • Gao-Yuan Wang,
  • Megan Iminitoff,
  • Tamara Beck,
  • Sue Haupt,
  • Yifang Hu,
  • Rose E. May,
  • Lachlan Whitehead,
  • Lin Tai,
  • William Chiang,
  • Marco J. Herold,
  • Ygal Haupt,
  • Gordon K. Smyth,
  • Tim Thomas,
  • Marnie E. Blewitt,
  • Andreas Strasser,
  • Anne K. Voss

Journal volume & issue
Vol. 27, no. 2
pp. 442 – 454.e5

Abstract

Read online

Summary: Neural tube defects (NTDs) are common birth defects in humans and show an unexplained female bias. Female mice lacking the tumor suppressor p53 display NTDs with incomplete penetrance. We found that the combined loss of pro-apoptotic BIM and p53 caused 100% penetrant, female-exclusive NTDs, which allowed us to investigate the female-specific functions of p53. We report that female p53−/− embryonic neural tube samples show fewer cells with inactive X chromosome markers Xist and H3K27me3 and a concomitant increase in biallelic expression of the X-linked genes, Huwe1 and Usp9x. Decreased Xist and increased X-linked gene expression was confirmed by RNA sequencing. Moreover, we found that p53 directly bound response elements in the X chromosome inactivation center (XIC). Together, these findings suggest p53 directly activates XIC genes, without which there is stochastic failure in X chromosome inactivation, and that X chromosome inactivation failure may underlie the female bias in neural tube closure defects. : The molecular mechanisms underlying the female bias of neural tube defects are currently unclear. Delbridge et al. present evidence that p53 is required for normal Xist expression and X chromosome inactivation and show in two models that partial failure of X chromosome inactivation is associated with female-biased neural tube defects. Keywords: female-specific neural tube defects, X-chromosome inactivation, p53, Xist, Ftx, Tsix, biallelic expression, BIM, BCL2L11, SMCHD1